To Our Original Aspiration, Embarking on a New Journey | Hycells Biological Relocates to New Headquarters
Release Date:
2022-12-19 11:13
Quality First, Innovation-Based
Quality First, Innovation Based
2022 was an extraordinary year for everyone. Although the pandemic restricted our movements, it only intensified our collective commitment to safeguarding human life and health. In November 2022, Hycells Biotechnology turned a new, milestone chapter in its history by relocating to a brand-new facility—marking a significant leap forward in the company’s manufacturing and R&D capabilities and providing a powerful boost to its sustained growth. Thanks to the concerted efforts of colleagues across all departments, we officially moved into our new premises on November 21, 2022.
No. 999, Jiangyue Road, Minhang District, Shanghai
Room 503, Building 2, Qiaite Center
Enterprise Consultation Hotline
021-36696819
In the midst of the pandemic, starting a business is undoubtedly even more challenging—especially for a startup like Hycells. Yet a hardworking, ambitious, and pragmatic team that unites its efforts, continuously learns and grows, steadily builds a solid foundation, and takes on greater corporate and social responsibilities can experience an unparalleled sense of pride and fulfillment.
In the midst of the pandemic, our forward momentum has never faltered; the company has consistently adhered to Quality First, Innovation as the Foundation Core values: Pursue excellence and continuously explore new horizons! The company’s new headquarters is located at No. 999 Jiangyue Road, Minhang District, Shanghai, and comprises office spaces, a reception area, laboratories, and more.
Hycells with Center on talent development, respect and cherish talent, ensure that those who deliver results are given appropriate roles, and empower those who take responsibility to assume it. Its business philosophy is committed to becoming a… A technology-driven innovation company specializing in providing cell and animal models for drug discovery, we empower more pharmaceutical R&D firms through high-quality technical research standards, a highly professional laboratory research team, rigorously ethical-compliant laboratory service procedures, and a robust technical support team. Hycells’s corporate ethos is unity and progress, physical strength, dynamic thinking, and unwavering conviction.
The company’s new headquarters houses multiple laboratories that offer a wide range of experimental services and operations, including cell preparation and isolation, pharmacological and efficacy evaluation, and clinical project management. The office’s leisure areas are spacious and well-lit, workstations are neatly organized, the break room is comfortable and tidy, and the potted plants in the meeting rooms thrive with vitality. These features not only meet employees’ workplace needs but also strive to provide a comfortable environment, fostering a positive corporate culture and creating a virtuous cycle of organizational well-being.
The relocation of Hycells to its new headquarters marks a significant milestone in the company’s development. Moving forward, we will continue to deepen our expertise in cell and gene therapy, further refine our clinical, technical, and business management systems and service processes, and provide professional sample collection and quality-control services to partners across the biopharmaceutical sector—ensuring the highest levels of compliance and safety in sample sourcing. At the same time, we remain committed to a people-first approach, with a focus on team growth, leveraging our deep technical expertise and a reputation for high customer satisfaction to support biopharmaceutical companies nationwide. Through ongoing internal development, we will continually enhance our service framework and institutional capabilities, expand the scope of our client offerings, and consistently empower the robust growth of the biopharmaceutical industry.
Following the housewarming ceremony, a series of fun mini-games were held on site, and a wide variety of exquisite little gifts were distributed to everyone, offering well-deserved recognition for their long-standing hard work and dedication.
Next page
Related News
(II) Security Assurance Section | Safety First, Defense Prioritized
Compliance‑driven traceability establishes a clear “identity” for the product, but the real test lies in safety. While a multi‑donor pooling strategy ensures batch‑to‑batch consistency, it also inevitably elevates the risk of pathogen introduction. In the face of these associated risks and challenges, Heyousheng has never compromised on its manufacturing standards—relying on more precise design to deliver on its promise of enhanced safety.
This article will examine how He Yousheng proactively integrates the quality management system into the hospital setting, translating compliance requirements into concrete, actionable practices starting at the sample collection stage, thereby establishing a trust‑based chain that can withstand audit scrutiny.
In selecting hPL raw materials, Heyousheng consistently upholds the principle that “safety is determined at the source.” The samples used in production are rigorously collected in accordance with applicable standards and undergo stringent donor screening, effectively mitigating the risk of disease transmission at the very outset. Moreover, from informed consent forms and ethical approvals to clinical‑grade collection under the GCP framework, Heyousheng has established a fully traceable documentation chain, ensuring that every sample is accounted for and verifiable. In contrast to the industry’s longstanding reliance on the conventional model of using expired blood supplies from blood banks, this approach represents a structural, generational upgrade.
Recently, the research team led by Researcher Bian Yingjie at the Guangzhou National Laboratory, in collaboration with partners from Sun Yat-sen University, published a study titled “Iron overload in the tumor microenvironment induces CD8⁺ T cell ferroptosis and dysfunction” in the internationally renowned academic journal Nature Communications.
Hycells Recruitment | Never Stop Exploring, Never Stop Innovating
The company consistently upholds its core values of “people‑centricity, quality first, and innovation as the foundation,” remains driven by technological innovation, and sets new industry benchmarks for domestic innovation, thereby laying a solid foundation for the development and global advancement of China’s innovative pharmaceutical sector.
The HiXpan® NK Serum-Free Culture Kit, Version 3.0, is manufactured in strict compliance with GMP standards, and its production system fully adheres to relevant guidelines and regulations, including the “818 Requirements,” positioning it for pharmaceutical‑grade manufacturing and applications.
Contact Us
Phone: 021-36696819
Mobile phone:13061948224(Ms. Yu)
Email:monika@hys-bio.com
Wuxi Headquarters: 4th Floor, No. 15-1, Xianfeng Middle Road, Anzhen Subdistrict, Xishan District, Wuxi City
Shanghai Branch: Room 503, Building 2, No. 999 Jiangyue Road, Minhang District, Shanghai
Official Website
WeChat Official Account
Message Board